Skip to content

study of Nilikadya Kumkumadyam cream in treatment of Vyanga

Formulation development of Nilikadya Kumkumadyam cream and open label clinical study in management of Vyanga(Melasma)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030253
Enrollment
30
Registered
2021-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nilikadya Kumkumadyam Cream: 10gms approximately 2 times daily.treatment of course- 21 days Control Intervention1: NIL: NIL

Sponsors

Dr Sneha Kailas Kapse
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient should be suffering from Vyanga (Melasma).

Exclusion criteria

Exclusion criteria: Pigmentation since birth like Nevus.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Nilikadya Kumkumadyam cream in the management of Vyanga (Melasma).Timepoint: 21 Days

Secondary

MeasureTime frame
Getting cured of the symptoms.Timepoint: 21 days

Countries

India

Contacts

Public ContactDr Nilima Dharkar

Dr D.Y. Patil College of Ayurved and research centre Pimpri,Pune -411018

dharkar.nilima07@gmail.com8390077907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026